HomeOrganizations › FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS

FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS

TX · Medical Research · EIN 263160079

10
Executives Disclosed
$5.4M
Annual Revenue
$44.9M
Total Assets
2.4:1
Internal Pay Ratio

FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS has 10 executives with disclosed compensation. The highest-paid executive, Allyson Berent (CHIEF SCIENCE OFFICER), received peak total compensation of $509,945. The sector average for Medical Research executives is $311K.


Top Executive Compensation Over Time


Executive Compensation

Name Title Peak Comp. Latest Comp. Years vs. Household
Allyson Berent CHIEF SCIENCE OFFICER $510K $510K 2018–2024 6.8x
Paula Evans FORMER OFFICER AND DIRECTO $369K $177K 2018–2022 4.9x
Debbie Guagliardo FORMER OFFICER AND DIRECTO $325K $251K 2019–2020 4.3x
Ryan K Fischer CHIEF OPERATING OFICER $286K $286K 2023–2024 3.8x
Alana Newhouse PRESIDENT/CEO $245K $245K 2022–2024 3.3x
Kena Pearson CHIEF FINANCIAL OFFICER $233K $233K 2024–2024 3.1x
Michele Golombuski CHIEF DEVELOPMENT OFFICER $210K $210K 2024–2024 2.8x
Kena Richert CHIEF FINANCIAL OFFICER $192K $192K 2020–2023 2.6x
Maiddy Dunigan FORMER OFFICER AND COO $152K $37K 2020–2023 2x
Deborah Guagliardo FORMER OFFICER AND DIRECTOR $142K $142K 2018–2018 1.9x

Annual Summary

Year Executives Avg. Comp. Highest Comp. Total Payroll
2018 3 $145K $146K $434K
2019 3 $354K $369K $1.1M
2020 5 $300K $325K $901K
2021 4 $239K $325K $954K
2022 4 $180K $188K $541K
2023 4 $151K $198K $605K
2024 5 $297K $510K $1.5M
Email Alerts

Get notified about FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS

Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.